Clinical Trials Browser

Phase 1 × Leukemia × Drug Evaluation × Clear all

NCT04840784 2023-10-11

First-in Human (FIH) Trial of ETH-155008 in Subjects With B-NHL, CLL/SLL and AML

Phase 1 Terminated

Other hematologic neoplasm

Leukemia